Max Urbanczyk
Impact in
-
- Electrospun Nanofibers in Biomedical Applications
-
- 3D Printing in Biomedical Research
Papers in
- Surgery 6
- Pancreatic function and diabetes 6
-
- Pluripotent Stem Cells Research 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Katja Schenke‐Layland (11 shared papers)Shannon L. Layland (9 shared papers)Aline Zbinden (6 shared papers)Garry P. Duffy (6 shared papers)Peter Loskill (5 shared papers)Julia Marzi (4 shared papers)Eva Brauchle (1 shared paper)Udo Kraushaar (1 shared paper)
- Journals
- Tissue Engineering Part A (3 papers)Matrix Biology (3 papers)Scientific Reports (1 paper)Advanced Healthcare Materials (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- GermanyIrelandUnited States
In The Last Decade
Max Urbanczyk
10 papers receiving 349 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 48
- Biomedical Engineering 148
- Surgery 131
- Cell Biology 50
- Biophysics 18
Countries citing papers authored by Max Urbanczyk
This map shows the geographic impact of Max Urbanczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Urbanczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Urbanczyk more than expected).
Fields of papers citing papers by Max Urbanczyk
This network shows the impact of papers produced by Max Urbanczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Urbanczyk. The network helps show where Max Urbanczyk may publish in the future.
Co-authors
The 15 scholars most cited alongside Max Urbanczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 144 | |
| 2 | 2019 | 74 | |
| 3 | 2019 | 48 | |
| 4 | 2022 | 28 | |
| 5 | 2020 | 21 | |
| 6 | 2021 | 14 | |
| 7 | 2020 | 8 | |
| 8 | 2022 | 8 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 0 |
About Max Urbanczyk
Max Urbanczyk is a scholar working on Surgery, Molecular Biology, Genetics, Endocrinology, Diabetes and Metabolism and Cell Biology, having authored 11 papers that have together received 350 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (6 papers), Diabetes and associated disorders (4 papers), Diabetes Management and Research (2 papers), Pluripotent Stem Cells Research (2 papers), 3D Printing in Biomedical Research (2 papers), Electrospun Nanofibers in Biomedical Applications (1 paper), Ubiquitin and proteasome pathways (1 paper) and Aortic Disease and Treatment Approaches (1 paper). The work is most often cited by research in Biomaterials (48 citations), Biomedical Engineering (148 citations), Surgery (131 citations), Cell Biology (50 citations) and Biophysics (18 citations). Max Urbanczyk has collaborated with scholars based in Germany, Ireland and United States. Frequent co-authors include Katja Schenke‐Layland, Shannon L. Layland, Aline Zbinden, Garry P. Duffy, Peter Loskill, Julia Marzi, Eva Brauchle, Udo Kraushaar, Christopher Probst and Tengku Ibrahim Maulana. Their work appears in journals such as Tissue Engineering Part A, Matrix Biology, Scientific Reports, Advanced Healthcare Materials and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.